Publications by authors named "Ruoding Tan"

Claim this Profile
E
Early-Onset Colorectal Cancer Survival by Race and Ethnicity in a Large Community-Based Insured Population.
James H-E Kang, Christopher D Jensen, Natalia Udaltsova, Jessica M Badalov, Bruce H Fireman, Ruoding Tan

Gastro Hep Adv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atezolizumab Plus Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma: Real-World Experience From a US Community Oncology Network.
David Cosgrove, Ruoding Tan, Andrew J Osterland, Sairy Hernandez, Sarika Ogale

J Hepatocell Carcinoma· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Significance of Recurrence and Timing of Recurrence on Survival Among Patients with Early-Stage Hepatocellular Carcinoma in U.S. Clinical Practice.
Shishir K Maithel, Rongrong Wang, Joanna Harton, Adam Yopp, Shimul A Shah, Ruoding Tan

Ann Surg Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Race/ethnicity and socioeconomic position in emergency department utilization in patients with hepatocellular carcinoma.
Daniel Lin, Ruoding Tan, Christie Teigland, Sairy Hernandez, Seung Kim

Future Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overall Survival in Real-World Patients with Unresectable Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab Versus Sorafenib or Lenvatinib as First-Line Therapy: Findings from the National Veterans Health Administration Database.
David E Kaplan, Ruoding Tan, Cheryl Xiang, Fan Mu, Sairy Hernandez

Cancers (Basel)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Why Liver Cancer Hits Home: Bridging Healthcare Disparities in the Asian American and Pacific Islander Community.
Daneng Li, Spencer Cheng, Andrea Wilson Woods, Allyson Luong, Sarah Schiltz, Ruoding Tan

J Hepatocell Carcinoma· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Preferences for Unresectable Hepatocellular Carcinoma Treatments: A Discrete-Choice Experiment.
Daneng Li, Ruoding Tan, Sairy Hernandez, Norelle Reilly, Cooper Bussberg

Cancers (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing Real-World Racial Differences Among Patients With Metastatic Triple-Negative Breast Cancer in US Community Practices.
Ruoding Tan, Lourenia Cassoli, Ying Yan, Vincent Shen, Bann-Mo Day

Front Public Health· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Immune Checkpoint Inhibitors on COVID-19 Severity in Patients with Cancer.
Ruoding Tan, Cindy Yun, Arpamas Seetasith, Daniel Sheinson, Robert Walls

Oncologist· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding the Gap Between Efficacy in Randomized Controlled Trials and Effectiveness in Real-World Use of GLP-1 RA and DPP-4 Therapies in Patients With Type 2 Diabetes.
Ginger S Carls, Edward Tuttle, Ruo-Ding Tan, Johnny Huynh, John Yee

Diabetes Care· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-Drug Interaction Associated with Mold-Active Triazoles among Hospitalized Patients.
David Andes, Nkechi Azie, Hongbo Yang, Rachel Harrington, Caroline Kelley, Ruo-Ding Tan

Antimicrob Agents Chemother· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brentuximab vedotin compared with other therapies in relapsed/refractory Hodgkin lymphoma post autologous stem cell transplant: median overall survival meta-analysis.
Vijayveer Bonthapally, Hongbo Yang, Rajeev Ayyagari, Ruo-Ding Tan, Sean Cai

Curr Med Res Opin· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world patterns of endocrine therapy for metastatic hormone-receptor-positive (HR+)/human epidermal growth factor receptor-2-negative (HER2-) breast cancer patients in the United States: 2002-2012.
Elyse Swallow, Jie Zhang, Darren Thomason, Ruo-Ding Tan, Andrew Kageleiry

Curr Med Res Opin· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment, monitoring, and economic outcomes of venous thromboembolism among hospitalized patients in China.
Eric Q Wu, Jipan Xie, Chun Wu, Ella Xiaoyan Du, Nanxin Li, Ruoding Tan

Pharmacoeconomics· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abortion before & after Roe.
Ted Joyce, Ruoding Tan, Yuxiu Zhang

J Health Econ· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis